A single treatment with Epioxa maintained improvements in corneal shape and vision for three years in a follow-up study of patients with keratoconus, according to its developer Glaukos. Glaukos said patients treated with Epioxa did not need additional intervention during the three-year follow-up. The results provide longer-term data on the treatment, which is designed to
Single Non-Surgical Treatment for Corneal Disease Shows Benefits for 3 Years
RELATED ARTICLES
